HeartWare Takes $282M Buyout
Ryan McBride2/13/09
HeartWare International (ASX:HIN), a small Framingham, MA-based developer of an implant used to keep the heart beating, has agreed to be sold to Pleasanton, CA-based medical devices firm Thoratec (NASDAQ:THOR) in a half stock, half cash deal valued at $282 million, according to Thoratec. The deal is expected to close in the second half of 2009. HeartWare CEO Doug Godshall, a former group president at Natick, MA-based medical devices giant Boston Scientific (NYSE:BSX), moved HeartWare’s main corporate office from Australia to Massachusetts after he took the reigns at the firm in 2006.
